Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8458724 | Radiotherapy and Oncology | 2018 | 9 Pages |
Abstract
Bowel morbidity reported in this large cohort of LACC patients was limited regarding severe/life-threatening events. Mild-moderate diarrhea, flatulence and incontinence were prevalent after treatment with PROs indicating a considerable and clinically relevant burden. Critical knowledge based on the extent and manifestation pattern of treatment-related morbidity will serve future patient management.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nina Boje Kibsgaard Jensen, Richard Pötter, Kathrin Kirchheiner, Lars Fokdal, Jacob Christian Lindegaard, Christian Kirisits, Renaud Mazeron, Umesh Mahantshetty, Ina Maria Jürgenliemk-Schulz, Barbara Segedin, Peter Hoskin, Kari Tanderup,